The global benign prostatic hyperplasia (BPH) treatment market is experiencing steady growth, driven by the rising prevalence of prostate-related disorders among the aging male population and increasing awareness regarding early diagnosis and treatment options. BPH, a non-cancerous enlargement of the prostate gland, is becoming increasingly common, thereby boosting demand for effective...